FDA Adverse Event Malfunction Summary report: N

VENTANA PD-L1 (SP142) ASSAY

MDR report key: 17173066 · Received June 21, 2023

Report

Report Number
2028492-2023-00032
Event Type
Malfunction
Date Received
June 21, 2023
Date of Event
May 23, 2023
Report Date
June 21, 2023
Manufacturer
VENTANA MEDICAL SYSTEMS INC
Product Code
PLS
PMA / PMN Number
P160002
Removal / Correction Number
Z-0907-2023 RES91199
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE MATERIAL NUMBER IS NOT MARKETED OR DISTRIBUTED IN THE US. HOWEVER, ROCHE OBSERVED UNACCEPTABLE, LIGHT STAINING WITH SOME VENTANA PD-L1 (SP142) ON-MARKET LOTS, DURING INTERNAL COMPARISON STUDIES. LIGHT STAINING AFFECTS THE BORDERLINE OF POSITIVE VERSUS NEGATIVE TEST RESULTS. AN ON-GOING INVESTIGATION HAS DETERMINED THE ROOT CAUSE IS RELATED TO VARIABILITY IN THE SELECTION OF ANTIBODY CONCENTRATION IN RAW MATERIALS, AFFECTING SPECIFIC VENTANA PD-L1 (SP142) ASSAY LOTS MADE WITH THE IMPACTED RAW MATERIALS. A NOTIFICATION HAS BEEN SENT TO US CUSTOMERS INFORMING THEM OF THE ISSUE TO IMMEDIATELY DISCONTINUE THE USE OF AND DISCARD ANY REMAINING INVENTORY OF SPECIFIC IMPACTED LOTS AND INFORMING OF AN UPDATED DATE OF EXPIRATION FOR CERTAIN LOTS. THE ALLEGED SAMPLE WAS INITIALLY TESTED ON 24 FEB 2022 AND WAS REPEATED ON 21 DEC 2022 AFTER RECEIVING THE NOTIFICATION. E1 FACILITY NAME TRUNCATED DUE TO CHARACTER LIMIT: SGH - HISTOPATHOLOGY LABORATORY (B)(6) HOSPITAL PTE LTD.

Description of Event or Problem · 0

A CUSTOMER FROM SINGAPORE ALLEGED DISCREPANT RESULTS WITH THE VENTANA PD-L1 (SP142) ASSAY. THE ALLEGED SAMPLE INITIALLY GENERATED A NEGATIVE RESULT WHICH WAS REPORTED TO MEDICAL PERSONNEL TREATING THE PATIENT. THE SAMPLE WAS THEN RETESTED USING THE SAME ASSAY AND GENERATED A POSITIVE RESULT; THE RESULT WAS SENT TO THE CLINICIAN. TO DATE, NO HARM IS ALLEGED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
749708 VENTANA PD-L1 (SP142) ASSAY PROGRAMMED DEATH-LIGAND 1 (PD-L1) IVD, ANTIBODY PLS VENTANA MEDICAL SYSTEMS INC NA H00001

Patients

Seq Age Sex Outcome Treatment
1 Unknown